4//SEC Filing
Orlinger Klaus 4
Accession 0001415889-24-010961
CIK 0001760542other
Filed
Apr 16, 8:00 PM ET
Accepted
Apr 17, 4:15 PM ET
Size
5.4 KB
Accession
0001415889-24-010961
Insider Transaction Report
Form 4
Orlinger Klaus
Sr. VP, Research
Transactions
- Award
Stock Option (Right to Buy)
2024-04-15+367,300→ 367,300 totalExercise: $0.76Exp: 2034-04-15→ Common Stock (367,300 underlying)
Footnotes (1)
- [F1]25% of this option shall vest on April 15, 2025, with the remainder vesting in 12 equal quarterly installments thereafter.
Documents
Issuer
HOOKIPA Pharma Inc.
CIK 0001760542
Entity typeother
Related Parties
1- filerCIK 0001768432
Filing Metadata
- Form type
- 4
- Filed
- Apr 16, 8:00 PM ET
- Accepted
- Apr 17, 4:15 PM ET
- Size
- 5.4 KB